Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8
Stefan Bauer(Technical University of Munich), Christoph Renner(Klinik Hirslanden), Nicole Adrian(Saarland University), Margarita Plesko(University Hospital Zurich), Gerd Ritter(Memorial Sloan Kettering Cancer Center), Natalie Fadle(Saarland University), Thomas Wüest(University Hospital Zurich), Lloyd J. Old(Gynecologic Oncology Group), Uta Siebenborn(Saarland University), Frank Stenner(University Hospital of Basel), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Alexander Knuth(National Center for Cancer Care and Research), Eliane Fischer(ETH Zurich)
Cited by 11
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
|Journal of Clinical Oncology|2000|2.3k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
Tumor-infiltrating NY-ESO-1–specific CD8 <sup>+</sup> T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
|Proceedings of the National Academy of Sciences|2010|844